Effect of a continuous diabetes lifestyle intervention program on male workers in Korea

Diabetes Research and Clinical Practice
Ji Yeon KangTae In Choi

Abstract

This study was conducted to compare the effects of two years of lifestyle intervention to no intervention or one year of intervention on diabetes risk factors in male workers with impaired fasting glucose (IFG) or diabetes. We conducted a randomized lifestyle intervention trial designed to alter personal lifestyles among 123 industrial male workers (CG; control group, n=75; OIG; one-year intervention group, n=23; TIG; two-year intervention group, n=25). The intervention consisted of two parts, the main program (face-to-face counseling five times/12 weeks) and a follow-up program (e-mail counseling ten times/30 weeks). Assessments included biochemical characteristics, anthropometry and nutrient intake at baseline and after two years. After two years, systolic blood pressure, HOMA-IR, HDL cholesterol and total energy intake (p<0.05) were reduced in the OIG group, while weight, body mass index, waist circumference, blood pressure, fasting plasma glucose (FPG), HbA1c and nutrient intake (total energy, carbohydrate, protein and sodium) were significantly decreased (p<0.05, respectively) in the TIG group. When compared to the CG, subjects in OIG and TIG showed significant improvements in the level of FPG and HbA1c (p<0.05). Continuou...Continue Reading

References

May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Sep 28, 2002·Diabetes Care·James B MeigsUNKNOWN Framingham Offspring Study
Mar 12, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M MensinkE E Blaak
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Nov 25, 2003·Diabetes Care·Jaana LindströmUNKNOWN Finnish Diabetes Prevention Study Group
Dec 3, 2004·Annals of Epidemiology·Elizabeth J Mayer-DavisUNKNOWN Diabetes Prevention Program Research Group
Jan 15, 2005·Diabetes Research and Clinical Practice·Kinori KosakaTakeshi Kuzuya
Apr 7, 2005·Diabetes Research and Clinical Practice·Hilde K BrekkePer-Anders Jansson
May 12, 2005·Diabetes Research and Clinical Practice·Hilde K BrekkeRagnhild A Lenner
Nov 22, 2005·Diabetes Research and Clinical Practice·John C OldroydK G M M Alberti
May 1, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·C RoumenE E Blaak
May 14, 2009·Diabetes Care·Monique A M Jacobs-van der BruggenCaroline A Baan

❮ Previous
Next ❯

Citations

Jul 23, 2015·Journal of Medical Internet Research·Dong-Chul Seo, Jingjing Niu
Jul 27, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Qian ZhaoYawen Liu
Aug 15, 2015·Circulation·Lora E BurkeUNKNOWN American Heart Association Publications Committee of the Council on Epidemiology and Prevention, Behavior Change Committee o
Jun 22, 2012·Wiener medizinische Wochenschrift·Christian WadsackUrsula Hiden
Jan 18, 2019·American Journal of Health Promotion : AJHP·Sankalp DasEmir Veledar
Nov 24, 2015·American Journal of Lifestyle Medicine·Karla I GalavizMary Beth Weber
Apr 2, 2020·International Journal of Environmental Research and Public Health·Won Ju Hwang, Soo Jin Kang
Oct 19, 2020·Journal of the Academy of Nutrition and Dietetics·Feon W ChengDeepa Handu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.